Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 1 policy sources
8 readers on Mendeley
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107104

Ethanol, acetaldehyde, and myocardial protein synthesis

Sidney S. Schreiber, Kay Briden, Murray Oratz, and Marcus A. Rothschild

Department of Nuclear Medicine, New York Veterans Hospital, New York 10010

Department of Medicine, New York University School of Medicine, New York 10010

Find articles by Schreiber, S. in: JCI | PubMed | Google Scholar

Department of Nuclear Medicine, New York Veterans Hospital, New York 10010

Department of Medicine, New York University School of Medicine, New York 10010

Find articles by Briden, K. in: JCI | PubMed | Google Scholar

Department of Nuclear Medicine, New York Veterans Hospital, New York 10010

Department of Medicine, New York University School of Medicine, New York 10010

Find articles by Oratz, M. in: JCI | PubMed | Google Scholar

Department of Nuclear Medicine, New York Veterans Hospital, New York 10010

Department of Medicine, New York University School of Medicine, New York 10010

Find articles by Rothschild, M. in: JCI | PubMed | Google Scholar

Published November 1, 1972 - More info

Published in Volume 51, Issue 11 on November 1, 1972
J Clin Invest. 1972;51(11):2820–2826. https://doi.org/10.1172/JCI107104.
© 1972 The American Society for Clinical Investigation
Published November 1, 1972 - Version history
View PDF
Abstract

The cause of alcoholic myocardiopathy is unknown. The effects of acute exposure to ethanol or its metabolite acetaldehyde on protein synthesis in working, intact, guinea pig hearts in vitro were studied utilizing lysine-14C perfusion. Ethanol at 250 mg/100 ml, a level sufficient to markedly inhibit hepatic production of albumin, did not alter cardiac function, the equilibration of the intracellular free lysine pool in either ventricle, or the incorporation of lysine-14C into protein. Thus, in controls and ethanol-perfused hearts, the incorporation of lysine in 3 hr was 44.1±1.5 and 42.8±1.2 μmoles lysine/g protein N for the right ventricles and 25.6±1.0 and 24.3±0.8 for the left ventricles, respectively. Only at lethal levels, 1500 mg/100 ml ethanol, was protein synthesis depressed. Acetaldehyde 3.5 mg/100 ml (0.8 mM) effected a markedly positive chronotropic and inotropic effect on the perfused heart and slightly depressed equilibration of the intracellular free lysine pool. However, determinations of protein incorporation of lysine-14C based on intracellular lysine-14C specific activities showed a significant decrease from control right and left ventricle values, to 27.1±2.8 and 14.9±1.9. Propanalol, which abolished the chronotropic effect, did not prevent the inhibition of protein synthesis. The studies suggest that acetaldehyde, which inhibits cardiac protein synthesis in vitro, may play a role in alcoholic myocardiopathy by interfering with normal myocardial protein synthesis.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2820
page 2820
icon of scanned page 2821
page 2821
icon of scanned page 2822
page 2822
icon of scanned page 2823
page 2823
icon of scanned page 2824
page 2824
icon of scanned page 2825
page 2825
icon of scanned page 2826
page 2826
Version history
  • Version 1 (November 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
8 readers on Mendeley
See more details